True Multiplexing with the nELISA
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.
True Multiplexing with the nELISA
Subscribe to Updates
Get the latest insights and updates delivered straight to your inbox weekly.
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.
True Multiplexing with the nELISA
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.
Access resource
True Multiplexing with the nELISA
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.
Download resource
Get the latest insights and updates delivered straight to your inbox weekly.
True Multiplexing with the nELISA
Get the latest insights and updates delivered straight to your inbox weekly.
In Brief
This white paper examines the limitations of traditional multiplexed ELISA systems, particularly the challenges posed by reagent-driven cross-reactivity (rCR), which compromise assay fidelity. It introduces nELISA as a breakthrough technology that eliminates these limitations, allowing for significantly increased content and throughput in protein quantification, from research to clinical applications.